Filing Details
- Accession Number:
- 0000886163-18-000026
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-27 18:39:26
- Reporting Period:
- 2018-02-23
- Accepted Time:
- 2018-02-27 18:39:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 886163 | Ligand Pharmaceuticals Inc | LGND | Pharmaceutical Preparations (2834) | 770160744 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1237556 | W Matthew Foehr | 3911 Sorrento Valley Boulevard, Ste 110 San Diego CA 92121 | President And Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-02-23 | 1,004 | $9.97 | 95,835 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-02-23 | 5,444 | $14.47 | 101,279 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-02-23 | 5,444 | $152.98 | 95,835 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2018-02-23 | 1,004 | $0.00 | 1,004 | $9.97 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2018-02-23 | 5,444 | $0.00 | 5,444 | $14.47 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 42,081 | 2021-04-18 | No | 4 | M | Direct | |
| 54,556 | 2022-02-09 | No | 4 | M | Direct |
Footnotes
- Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 04/18/11.
- Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/09/12.
Billionaire Hedge Funds
